Bausch Health Companies (BHC) vs Phibro Animal Health (PAHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Phibro Animal Health (PAHC) has outperformed Bausch Health Companies (BHC) over the past year, gaining 0.8% versus a loss of 4.7%. Over five years, PAHC leads with a +71.6% price change compared with -78.8% for BHC. Bausch Health Companies is the larger company by market cap ($2.26 billion vs $1.52 billion), about 1.5 times the size.
On valuation, Bausch Health Companies trades at a lower forward P/E (1.4x vs 9.7x for Phibro Animal Health). Phibro Animal Health pays a dividend yielding 1.28%, while Bausch Health Companies does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BHC | PAHC |
|---|---|---|
| Share price | $6.04 | $37.40 |
| Market cap | $2.26B | $1.52B |
| 1-day change | -1.79% | -0.85% |
| YTD return | -13.09% | +0.11% |
| 1-year return | -4.73% | +0.78% |
| 5-year return | -78.80% | +71.56% |
| P/E ratio (TTM) | — | 15.39 |
| Forward P/E | 1.44 | 9.73 |
| EPS (TTM) | $-2.90 | $2.43 |
| Dividend yield | 0.00% | 1.28% |
| Annual dividend | $0.00 | $0.48 |
| 52-week high | $8.00 | $60.08 |
| 52-week low | $4.33 | $28.25 |
| Distance from 52-week high | -24.50% | -37.75% |
| Analyst consensus | hold | hold |
| Avg. price target upside | +24.17% | +17.65% |
| Average volume | 3.24M | 236.19K |
| Shares outstanding | 373.99M | 21.11M |
| Employees | 20,300 | 2,605 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Phibro Animal Health offers a meaningfully higher dividend yield (1.28% vs 0.00%).
About Bausch Health Companies
BHC stock →Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Health Care · Biotechnology: Pharmaceutical Preparations · 20,300 employees
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,605 employees
BHC vs PAHC FAQ
Which is bigger, Bausch Health Companies or Phibro Animal Health?
Bausch Health Companies (BHC) is larger, with a market capitalization of $2.26B compared with $1.52B for Phibro Animal Health (PAHC).
Which stock has performed better over the past year, BHC or PAHC?
PAHC returned +0.78% over the past 12 months, compared with -4.73% for BHC (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Bausch Health Companies or Phibro Animal Health?
Phibro Animal Health pays a dividend yielding 1.28%, while Bausch Health Companies does not currently pay a regular dividend.
Are Bausch Health Companies and Phibro Animal Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.